Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionsialic acid binding

SIGLEC9 SIGLEC14 SIGLEC5 SIGLEC7 CD33

1.09e-06251515GO:0033691
GeneOntologyMolecularFunctiondecanoate-CoA ligase activity

ACSM4 ACSM2A ACSM2B

1.69e-0641513GO:0102391
GeneOntologyMolecularFunctionvoltage-gated monoatomic ion channel activity

CACNA1S HCN1 GRIN1 P2RX5 CLCN7 SCN1A SCN2A KCNJ16 KCNN2

1.04e-051821519GO:0005244
GeneOntologyMolecularFunctionvoltage-gated channel activity

CACNA1S HCN1 GRIN1 P2RX5 CLCN7 SCN1A SCN2A KCNJ16 KCNN2

1.13e-051841519GO:0022832
GeneOntologyMolecularFunctionfatty-acyl-CoA synthase activity

ACSM4 ACSM2A ACSM2B

2.31e-0581513GO:0004321
GeneOntologyMolecularFunctionmedium-chain fatty acid-CoA ligase activity

ACSM4 ACSM2A ACSM2B

6.69e-05111513GO:0031956
GeneOntologyMolecularFunctionmonosaccharide binding

SIGLEC9 SIGLEC14 SIGLEC5 IGF2R SIGLEC7 G6PD

8.46e-05951516GO:0048029
GeneOntologyMolecularFunctionbenzoate-CoA ligase activity

ACSM2A ACSM2B

1.70e-0431512GO:0018858
GeneOntologyMolecularFunctionATP-dependent activity

DNHD1 ABCC3 ERCC2 SPG7 DDX60 MYO1H ABCB5 BTAF1 LONP1 ACSM4 ABCB8 ACSM2A DNAH6 ACSM2B

2.40e-0461415114GO:0140657
GeneOntologyMolecularFunctioncarboxylic acid binding

SIGLEC9 SIGLEC14 SIGLEC5 GRIN1 IGF2R SIGLEC7 CD33 FURIN

4.79e-042391518GO:0031406
GeneOntologyMolecularFunctionC-acyltransferase activity

ACSM4 ACSM2A ACSM2B

5.10e-04211513GO:0016408
GeneOntologyMolecularFunctioncarboxypeptidase activity

VASH1 CPVL CTSV AGTPBP1

5.11e-04491514GO:0004180
GeneOntologyMolecularFunctionreceptor signaling protein tyrosine kinase activator activity

LTK ALK

5.60e-0451512GO:0030298
GeneOntologyMolecularFunctionorganic acid binding

SIGLEC9 SIGLEC14 SIGLEC5 GRIN1 IGF2R SIGLEC7 CD33 FURIN

7.14e-042541518GO:0043177
GeneOntologyMolecularFunctionstructural constituent of eye lens

CRYGA CRYGB CRYGC

7.64e-04241513GO:0005212
GeneOntologyMolecularFunctionamino acid:proton symporter activity

SLC25A18 SLC25A22

8.35e-0461512GO:0005280
GeneOntologyMolecularFunctionsolute:proton symporter activity

SLC25A18 SLC25A22 SLC45A2

8.63e-04251513GO:0015295
GeneOntologyMolecularFunctionfatty acid ligase activity

ACSM4 ACSM2A ACSM2B

9.70e-04261513GO:0015645
GeneOntologyMolecularFunctionvoltage-gated sodium channel activity

HCN1 SCN1A SCN2A

9.70e-04261513GO:0005248
GeneOntologyMolecularFunctiongated channel activity

CACNA1S HCN1 GRIN1 P2RX5 CLCN7 SCN1A SCN2A KCNJ16 KCNN2

1.02e-033341519GO:0022836
GeneOntologyMolecularFunctionCoA-ligase activity

ACSM4 ACSM2A ACSM2B

1.09e-03271513GO:0016405
GeneOntologyMolecularFunctioncalcium ion sensor activity

EFHD1 SYT1

1.16e-0371512GO:0061891
GeneOntologyMolecularFunctiontransmembrane receptor protein tyrosine kinase activity

DDR1 IGF2R LTK ALK

1.49e-03651514GO:0004714
GeneOntologyMolecularFunctiontransmembrane transporter activity

ABCC3 CACNA1S SLC25A18 HCN1 ABCB5 PEX12 GRIN1 NDUFS2 SLC25A22 P2RX5 CLCN7 GSDMD SCN1A SCN2A SLC22A2 ABCB8 KCNJ16 KCNN2 SLC45A2

1.49e-03118015119GO:0022857
GeneOntologyMolecularFunctionexopeptidase activity

VASH1 JMJD7 CPVL CTSV AGTPBP1

1.50e-031101515GO:0008238
GeneOntologyMolecularFunctionATP-dependent peptidase activity

SPG7 LONP1

1.54e-0381512GO:0004176
GeneOntologyMolecularFunctionmetal ion sensor activity

EFHD1 SYT1

1.54e-0381512GO:0140784
GeneOntologyMolecularFunctionacid-thiol ligase activity

ACSM4 ACSM2A ACSM2B

1.63e-03311513GO:0016878
GeneOntologyMolecularFunctionxenobiotic transmembrane transporter activity

ABCC3 ABCB5 SLC22A2

2.14e-03341513GO:0042910
HumanPhenoPes valgus

WDR19 LONP1 SCN1A PCDH19 SCN2A SMG9 SYT1

4.54e-0656637HP:0008081
HumanPhenoGlobal brain atrophy

DOHH ERCC2 HCN1 GRIN1 SLC25A22 SCN1A PCDH19 SCN2A SMG9 AGTPBP1

5.77e-061386310HP:0002283
HumanPhenoAtonic seizure

DOHH HCN1 GRIN1 SLC25A22 MTOR SCN1A PCDH19 SCN2A

1.68e-0594638HP:0010819
HumanPhenoAortopulmonary collateral arteries

SLC25A22 ALDH1A2 SCN1A SCN2A

2.62e-0515634HP:0031834
HumanPhenoThoracic dysplasia

IFT172 WDR19 WDR35

3.51e-056633HP:0006644
HumanPhenoObsessive-compulsive trait

HCN1 SCN1A PCDH19 SCN2A DMPK

4.48e-0533635HP:0008770
HumanPhenoFocal emotional seizure with laughing

GRIN1 SLC25A22 SCN1A SCN2A

4.48e-0517634HP:0010821
HumanPhenoGeneralized clonic seizure

GRIN1 SLC25A22 SCN1A PCDH19 SCN2A

5.20e-0534635HP:0011169
HumanPhenoFocal emotional seizure

GRIN1 SLC25A22 SCN1A SCN2A

5.71e-0518634HP:0025613
HumanPhenoEEG with focal epileptiform discharges

GRIN1 SLC25A22 LONP1 MTOR SCN1A PCDH19 SCN2A SYT1

8.73e-05118638HP:0011185
HumanPhenoEEG with spike-wave complexes

HCN1 GRIN1 SLC25A22 MTOR SCN1A SCN2A SYT1

9.12e-0588637HP:0010850
HumanPhenoPhotosensitive myoclonic seizure

SCN1A PCDH19 SCN2A

9.66e-058633HP:0001327
HumanPhenoCyanotic episode

SCN1A PCDH19 SCN2A

9.66e-058633HP:0200048
HumanPhenoAbnormality of coordination

DOHH ERCC2 SPG7 NMNAT1 IFT172 HCN1 GDAP1 PEX12 GRIN1 NDUFS2 IVD WDR19 SLC25A22 LIMK1 LONP1 EEF2 PNPLA6 SCN1A PCDH19 SCN2A TMEM70 KCNJ16 KCNN2 SMG9 SYT1 RNASEH1 DMPK ALK AGTPBP1

1.06e-0412276329HP:0011443
HumanPhenoFocal non-motor seizure

GRIN1 SLC25A22 SCN1A PCDH19 SCN2A

1.16e-0440635HP:0032679
HumanPhenoChoreoathetosis

ERCC2 IREB2 GRIN1 SLC25A22 LONP1 SCN1A SCN2A SYT1

1.17e-04123638HP:0001266
HumanPhenoGeneralized tonic seizure

GRIN1 SLC25A22 LONP1 SCN1A PCDH19 SCN2A

1.20e-0464636HP:0010818
HumanPhenoAbnormal nervous system electrophysiology

CACNA1S HSPG2 FBLN5 ERCC2 SPG7 NMNAT1 HCN1 GDAP1 PEX12 IREB2 GRIN1 TUBGCP2 NDUFS2 SLC25A22 LONP1 CLCN7 MTOR SCN1A PCDH19 SCN2A WDR35 SMG9 SYT1 RNASEH1

1.39e-049246324HP:0001311
HumanPhenoIncoordination

DOHH ERCC2 SPG7 NMNAT1 IFT172 HCN1 GDAP1 PEX12 GRIN1 NDUFS2 IVD WDR19 SLC25A22 LIMK1 LONP1 EEF2 PNPLA6 SCN1A PCDH19 SCN2A TMEM70 KCNJ16 KCNN2 SMG9 SYT1 RNASEH1 ALK AGTPBP1

1.52e-0411846328HP:0002311
HumanPhenoTibial torsion

HCN1 SCN1A PCDH19 SCN2A

1.58e-0423634HP:0100694
HumanPhenoPoor fine motor coordination

HCN1 GDAP1 SCN1A PCDH19 SCN2A DMPK

1.83e-0469636HP:0007010
HumanPhenoAtaxia

DOHH ERCC2 SPG7 NMNAT1 IFT172 HCN1 PEX12 GRIN1 NDUFS2 IVD WDR19 SLC25A22 LIMK1 LONP1 EEF2 PNPLA6 SCN1A PCDH19 SCN2A TMEM70 KCNJ16 KCNN2 SYT1 RNASEH1 ALK AGTPBP1

2.06e-0410736326HP:0001251
HumanPhenoFocal hemiclonic seizure

SLC25A22 SCN1A PCDH19 SCN2A

2.21e-0425634HP:0006813
HumanPhenoEEG with focal spikes

LONP1 MTOR SCN2A SYT1

2.59e-0426634HP:0011193
HumanPhenoLimited neck range of motion

SCN1A PCDH19 SCN2A

2.77e-0411633HP:0000466
HumanPhenoLimited knee extension

HCN1 SCN1A PCDH19 SCN2A

3.01e-0427634HP:0003066
HumanPhenoStatus epilepticus without prominent motor symptoms

HCN1 SCN1A PCDH19 SCN2A

3.01e-0427634HP:0031475
HumanPhenoVisual impairment

HSPG2 DOHH ERCC2 NMNAT1 IFT172 RBP3 PEX12 GRIN1 TUBGCP2 NDUFS2 WDR19 SLC25A22 CRYGC LIMK1 LONP1 PNPLA6 CLCN7 MTOR SCN1A SCN2A ASPH KCNN2 SMG9 SYT1 SLC45A2 RNASEH1 AGTPBP1

3.54e-0411746327HP:0000505
HumanPhenoEpilepsia partialis continua

SCN1A PCDH19 SCN2A

3.66e-0412633HP:0012847
HumanPhenoEEG with focal sharp waves

LONP1 SCN1A SYT1

3.66e-0412633HP:0011196
HumanPhenoAbnormality of central nervous system electrophysiology

HSPG2 ERCC2 SPG7 NMNAT1 HCN1 PEX12 IREB2 GRIN1 TUBGCP2 NDUFS2 SLC25A22 LONP1 CLCN7 MTOR SCN1A PCDH19 SCN2A WDR35 SMG9 SYT1

3.67e-047386320HP:0030178
HumanPhenoBrain very small

HSPG2 DOHH ERCC2 SPG7 PCDHGC4 NMNAT1 HCN1 GRIN1 NDUFS2 SLC25A22 SMG8 LIMK1 LONP1 SCN1A PCDH19 SCN2A TMEM70 SMG9 RNASEH1 DMPK AGTPBP1

3.99e-048026321HP:0001322
HumanPhenoBrain atrophy

HSPG2 DOHH ERCC2 SPG7 PCDHGC4 NMNAT1 HCN1 GRIN1 NDUFS2 SLC25A22 SMG8 LIMK1 LONP1 SCN1A PCDH19 SCN2A TMEM70 SMG9 RNASEH1 DMPK AGTPBP1

3.99e-048026321HP:0012444
HumanPhenoClonic seizure

HCN1 GRIN1 SLC25A22 SCN1A PCDH19 SCN2A

4.42e-0481636HP:0020221
HumanPhenoProgressive gait ataxia

EEF2 SCN1A PCDH19 SCN2A

4.58e-0430634HP:0007240
HumanPhenoProgressive ataxia

EEF2 SCN1A PCDH19 SCN2A

4.58e-0430634HP:0001329
HumanPhenoGeneralized cerebral atrophy/hypoplasia

HCN1 SCN1A SCN2A

4.72e-0413633HP:0007058
HumanPhenoDelayed myelination

DOHH NMNAT1 IREB2 GRIN1 SLC25A22 CLCN7 SCN1A SCN2A KCNN2 SMG9 SYT1

5.40e-042806311HP:0012448
HumanPhenoPoor motor coordination

HCN1 GDAP1 SCN1A PCDH19 SCN2A DMPK

5.74e-0485636HP:0002275
HumanPhenoCogwheel rigidity

SCN1A PCDH19 SCN2A KCNN2

5.89e-0432634HP:0002396
DomainHEAT_REPEAT

DOHH COPG1 COPG2 BTAF1 NCAPG MTOR

1.86e-05701476PS50077
DomainCoatomer_g_Cpla

COPG1 COPG2

6.15e-0521472IPR032154
DomainSmg8/Smg9

SMG8 SMG9

6.15e-0521472IPR019354
Domain-

COPG1 COPG2

6.15e-05214722.60.40.1480
DomainSmg8_Smg9

SMG8 SMG9

6.15e-0521472PF10220
DomainCOP-gamma_platf

COPG1 COPG2

6.15e-0521472PF08752
DomainCoatomer_g_Cpla

COPG1 COPG2

6.15e-0521472PF16381
DomainCoatomer_gsu_app_Ig-like-sub

COPG1 COPG2

6.15e-0521472IPR013040
DomainCoatomer_gsu

COPG1 COPG2

6.15e-0521472IPR017106
DomainTyr_kinase_rcpt_2_CS

DDR1 LTK ALK

7.53e-05111473IPR002011
DomainRECEPTOR_TYR_KIN_II

DDR1 LTK ALK

9.98e-05121473PS00239
DomainP-loop_NTPase

DNHD1 MAGI1 ABCC3 ERCC2 SPG7 DDX60 ABCB5 ARL9 BTAF1 RIT2 MAGI2 LONP1 EEF2 ABCB8 SMG9 RAB7B DNAH6 CARD14

1.23e-0484814718IPR027417
DomainBeta/gamma_crystallin

CRYGA CRYGB CRYGC

2.03e-04151473IPR001064
DomainCRYSTALLIN_BETA_GAMMA

CRYGA CRYGB CRYGC

2.03e-04151473PS50915
DomainCrystall

CRYGA CRYGB CRYGC

2.03e-04151473PF00030
DomainXTALbg

CRYGA CRYGB CRYGC

2.03e-04151473SM00247
Domain-

DNHD1 ABCC3 ERCC2 SPG7 DDX60 ABCB5 ARL9 BTAF1 RIT2 LONP1 EEF2 ABCB8 SMG9 RAB7B DNAH6 CARD14

2.66e-04746147163.40.50.300
DomainAMP-bd_C

ACSM4 ACSM2A ACSM2B

3.00e-04171473IPR025110
DomainAMP-binding_C

ACSM4 ACSM2A ACSM2B

3.00e-04171473PF13193
DomainG_crystallin-rel

CRYGA CRYGB CRYGC

3.57e-04181473IPR011024
DomainARM-type_fold

DOHH COPG1 IFT172 COPG2 NCBP1 BTAF1 NCAPG MTOR CFAP69 AGTPBP1

3.59e-0433914710IPR016024
DomainClathrin_a/coatomer_app_sub_C

COPG1 COPG2

3.65e-0441472IPR015873
Domain-

COPG1 COPG2

3.65e-04414723.30.310.30
Domain-

DOHH COPG1 COPG2 BTAF1 NCAPG MTOR CFAP69 AGTPBP1

3.80e-0422214781.25.10.10
DomainGUANYLATE_KINASE_2

MAGI1 MAGI2 CARD14

7.54e-04231473PS50052
DomainGUANYLATE_KINASE_1

MAGI1 MAGI2 CARD14

7.54e-04231473PS00856
Domainig

SEMA3F HSPG2 SIGLEC9 SIGLEC14 SIGLEC5 SIGLEC7 CD33

7.76e-041901477PF00047
DomainImmunoglobulin

SEMA3F HSPG2 SIGLEC9 SIGLEC14 SIGLEC5 SIGLEC7 CD33

7.76e-041901477IPR013151
DomainABC_membrane

ABCC3 ABCB5 ABCB8

8.56e-04241473PF00664
DomainNa_trans_cytopl

SCN1A SCN2A

9.04e-0461472PF11933
DomainNa_trans_cytopl

SCN1A SCN2A

9.04e-0461472IPR024583
DomainHaem_d1

EML6 WDR19

9.04e-0461472IPR011048
DomainAAA

ABCC3 SPG7 ABCB5 LONP1 ABCB8 DNAH6

9.82e-041441476SM00382
DomainAAA+_ATPase

ABCC3 SPG7 ABCB5 LONP1 ABCB8 DNAH6

9.82e-041441476IPR003593
DomainGuanylate_kin

MAGI1 MAGI2 CARD14

1.09e-03261473PF00625
DomainAMP-binding_CS

ACSM4 ACSM2A ACSM2B

1.09e-03261473IPR020845
DomainGK/Ca_channel_bsu

MAGI1 MAGI2 CARD14

1.09e-03261473IPR008145
DomainGuanylate_kin-like_dom

MAGI1 MAGI2 CARD14

1.09e-03261473IPR008144
DomainGuKc

MAGI1 MAGI2 CARD14

1.09e-03261473SM00072
DomainHEAT

DOHH BTAF1 NCAPG MTOR

1.12e-03581474IPR000357
DomainProt_inhib_I29

CTSV CTSS

1.26e-0371472IPR013201
DomainInhibitor_I29

CTSV CTSS

1.26e-0371472PF08246
DomainInhibitor_I29

CTSV CTSS

1.26e-0371472SM00848
DomainABC_TM1F

ABCC3 ABCB5 ABCB8

1.35e-03281473PS50929
DomainAMP_BINDING

ACSM4 ACSM2A ACSM2B

1.35e-03281473PS00455
DomainABC1_TM_dom

ABCC3 ABCB5 ABCB8

1.35e-03281473IPR011527
DomainARM-like

DOHH COPG1 COPG2 BTAF1 NCAPG MTOR CFAP69 AGTPBP1

1.36e-032701478IPR011989
DomainAMP-binding

ACSM4 ACSM2A ACSM2B

1.66e-03301473PF00501
DomainAMP-dep_Synth/Lig

ACSM4 ACSM2A ACSM2B

1.66e-03301473IPR000873
DomainCoatomer/calthrin_app_sub_C

COPG1 COPG2

1.67e-0381472IPR009028
DomainKelch_1

KLHL10 KLHDC2 KLHL34 KLHL26

2.26e-03701474PF01344
DomainKelch_1

KLHL10 KLHDC2 KLHL34 KLHL26

2.26e-03701474IPR006652
DomainTPR-like_helical_dom

IFT172 WDR19 MTOR CTR9 ASPH WDR35 PRMT9

2.50e-032331477IPR011990
DomainNa_channel_asu

SCN1A SCN2A

2.66e-03101472IPR001696
DomainPept_asp_AS

CTSV CTSS

2.66e-03101472IPR025661
DomainNa_trans_assoc

SCN1A SCN2A

2.66e-03101472IPR010526
DomainNa_trans_assoc

SCN1A SCN2A

2.66e-03101472PF06512
DomainPept_his_AS

CTSV CTSS

3.23e-03111472IPR025660
DomainV-set

HSPG2 SIGLEC9 SIGLEC14 SIGLEC5 SIGLEC7 CD33

3.39e-031841476PF07686
DomainCoatomer/clathrin_app_Ig-like

COPG1 COPG2

3.86e-03121472IPR013041
DomainABC_transporter_CS

ABCC3 ABCB5 ABCB8

4.38e-03421473IPR017871
DomainPept_C1

CTSV CTSS

4.53e-03131472SM00645
DomainPeptidase_C1A_C

CTSV CTSS

4.53e-03131472IPR000668
DomainPeptidase_C1

CTSV CTSS

4.53e-03131472PF00112
DomainPeptidase_C1A

CTSV CTSS

4.53e-03131472IPR013128
DomainBTB-kelch_protein

KLHL10 KLHL34 KLHL26

4.68e-03431473IPR017096
DomainIg_V-set

HSPG2 SIGLEC9 SIGLEC14 SIGLEC5 SIGLEC7 CD33

4.96e-031991476IPR013106
DomainDynein_HC_stalk

DNHD1 DNAH6

5.26e-03141472IPR024743
DomainDynein_heavy_dom-2

DNHD1 DNAH6

5.26e-03141472IPR013602
DomainDHC_N2

DNHD1 DNAH6

5.26e-03141472PF08393
DomainMT

DNHD1 DNAH6

5.26e-03141472PF12777
DomainWW

MAGI1 CMTR1 MAGI2

6.01e-03471473PF00397
DomainDHC_fam

DNHD1 DNAH6

6.04e-03151472IPR026983
DomainClathrin/coatomer_adapt-like_N

COPG1 COPG2

6.04e-03151472IPR002553
DomainDynein_heavy

DNHD1 DNAH6

6.04e-03151472PF03028
DomainAdaptin_N

COPG1 COPG2

6.04e-03151472PF01602
DomainDynein_heavy_dom

DNHD1 DNAH6

6.04e-03151472IPR004273
DomainABC_tran

ABCC3 ABCB5 ABCB8

6.38e-03481473PF00005
DomainWW

MAGI1 CMTR1 MAGI2

6.38e-03481473SM00456
DomainABC_TRANSPORTER_2

ABCC3 ABCB5 ABCB8

6.38e-03481473PS50893
DomainABC_TRANSPORTER_1

ABCC3 ABCB5 ABCB8

6.75e-03491473PS00211
DomainGuanylate_kinase_CS

MAGI1 MAGI2

6.87e-03161472IPR020590
DomainABC_transporter-like

ABCC3 ABCB5 ABCB8

7.15e-03501473IPR003439
DomainWW_DOMAIN_1

MAGI1 CMTR1 MAGI2

7.55e-03511473PS01159
DomainWW_DOMAIN_2

MAGI1 CMTR1 MAGI2

7.55e-03511473PS50020
PathwayWP_DRAVET_SYNDROME

HCN1 MTOR SCN1A PCDH19 SCN2A

2.92e-06281165M45519
PathwayREACTOME_CONJUGATION_OF_SALICYLATE_WITH_GLYCINE

ACSM4 ACSM2A ACSM2B

1.07e-0561163MM14693
PathwayREACTOME_AMINO_ACID_CONJUGATION

ACSM4 ACSM2A ACSM2B

1.86e-0571163MM14598
PathwayREACTOME_AMINO_ACID_CONJUGATION

ACSM4 ACSM2A ACSM2B

4.40e-0591163M26968
PathwayREACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION

DOHH EEF2 JMJD7 FURIN ASPH

1.43e-04611165M26993
Pubmed

CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder.

SIGLEC9 SIGLEC14 SIGLEC5 SIGLEC7 CD33

1.81e-0913151535921817
Pubmed

The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils.

SIGLEC9 SIGLEC14 SIGLEC5 SIGLEC7

1.18e-087151415048729
Pubmed

[Functions and molecular evolution of Siglecs, a family of sialic acid receptor proteins].

SIGLEC9 SIGLEC14 SIGLEC5 SIGLEC7

1.18e-087151418453149
Pubmed

Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.

SIGLEC9 SIGLEC5 SIGLEC7 CD33

7.03e-0810151425320078
Pubmed

Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors.

SIGLEC9 SIGLEC5 SIGLEC7

8.02e-083151316828866
Pubmed

Selective Response to Bacterial Infection by Regulating Siglec-E Expression.

SIGLEC9 SIGLEC14 SIGLEC5 SIGLEC7

1.10e-0711151432889432
Pubmed

Homology models of human gamma-crystallins: structural study of the extensive charge network in gamma-crystallins.

CRYGA CRYGB CRYGC

3.20e-074151312507494
Pubmed

Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides.

SIGLEC9 SIGLEC5 SIGLEC7

3.20e-074151316732727
Pubmed

Differential regulation of gamma-crystallin genes during mouse lens development.

CRYGA CRYGB CRYGC

3.20e-07415133792630
Pubmed

The mouse eye lens obsolescence (Elo) mutant: studies on crystallin gene expression and linkage analysis between the mutant locus and the gamma-crystallin genes.

CRYGA CRYGB CRYGC

3.20e-07415133428594
Pubmed

Novel mutations in the gamma-crystallin genes cause autosomal dominant congenital cataracts.

CRYGA CRYGB CRYGC

3.20e-074151312011157
Pubmed

Genetic and allelic heterogeneity of Cryg mutations in eight distinct forms of dominant cataract in the mouse.

CRYGA CRYGB CRYGC

3.20e-074151315037589
Pubmed

Assignment of the human gamma-crystallin gene cluster (CRYG) to the long arm of chromosome 2, region q33-36.

CRYGA CRYGB CRYGC

3.20e-07415133011643
Pubmed

Temporal regulation of six crystallin transcripts during mouse lens development.

CRYGA CRYGB CRYGC

3.20e-07415131623964
Pubmed

Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996.

INHA CRYGA CRYGB CRYGC SCN1A SCN2A

6.88e-077115168751373
Pubmed

The crystallins: genes, proteins and diseases.

CRYGA CRYGB CRYGC

7.97e-07515139426193
Pubmed

Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes.

SIGLEC5 SIGLEC7 CD33

7.97e-075151311943481
Pubmed

The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsis.

SIGLEC9 SIGLEC5 SIGLEC7

7.97e-075151337890368
Pubmed

Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst.

SIGLEC9 SIGLEC7 CD33

7.97e-075151324227736
Pubmed

Structure of the crystallins.

CRYGA CRYGB CRYGC

7.97e-075151310627816
Pubmed

SMG-8 and SMG-9, two novel subunits of the SMG-1 complex, regulate remodeling of the mRNA surveillance complex during nonsense-mediated mRNA decay.

NCBP1 SMG8 EEF2 SMG9

1.57e-0620151419417104
Pubmed

Human gamma-crystallin genes. A gene family on its way to extinction.

CRYGA CRYGB CRYGC

1.59e-06615132258929
Pubmed

DM, but not cathepsin L, is required to control an aerosol infection with Mycobacterium tuberculosis.

DMPK CTSV CTSS

1.59e-066151318591414
Pubmed

Gamma-crystallins of the human eye lens: expression analysis of five members of the gene family.

CRYGA CRYGB CRYGC

1.59e-06615133670288
Pubmed

mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.

SIGLEC9 SIGLEC7 CD33

2.77e-067151311171044
Pubmed

Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.

SCN1A PCDH19 SCN2A

2.77e-067151325818041
Pubmed

Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms.

SIGLEC9 SIGLEC14 SIGLEC5 SIGLEC7

3.39e-0624151415331780
Pubmed

Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1.

SIGLEC9 SIGLEC5 SIGLEC7

4.42e-068151325187624
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

CEP85 RBL1 POGK ACOT9 BTAF1 SMG8 NUP155 GTF3C1 CTR9 ASPH CHPF2 EDEM1 EPB41L1

5.72e-066501511338777146
Pubmed

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

FBLN5 CMTR1 COPG1 ACOT9 COPG2 RBM28 TUBGCP2 FOXRED2 IGF2R MTOR CHPF2 GCC1 MPHOSPH6 RNASEH1

5.76e-067541511433060197
Pubmed

CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.

COPG1 COPG2 BTAF1 TUBGCP2 SLC25A22 PNPLA6

6.48e-06104151631240132
Pubmed

AAA+ proteins RUVBL1 and RUVBL2 coordinate PIKK activity and function in nonsense-mediated mRNA decay.

NCBP1 SMG8 EEF2 SMG9

7.45e-0629151420371770
Pubmed

Sox1 directly regulates the gamma-crystallin genes and is essential for lens development in mice.

CRYGA CRYGB CRYGC

9.41e-061015139512512
Pubmed

Regulation of lens fiber cell differentiation by transcription factor c-Maf.

CRYGA CRYGB CRYGC

9.41e-0610151310383433
Pubmed

Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions.

CRYGA CRYGB CRYGC

1.29e-0511151310595510
Pubmed

Multiple developmental defects derived from impaired recruitment of ASC-2 to nuclear receptors in mice: implication for posterior lenticonus with cataract.

CRYGA CRYGB CRYGC

1.29e-0511151312446761
Pubmed

E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.

CRYGA CRYGB CRYGC

1.29e-0511151311146559
Pubmed

Defining the membrane proteome of NK cells.

GALNT1 GDAP1 TUBGCP2 LONP1 EEF2 NCAPG IGF2R PNPLA6 NUP155 GTF3C1 CLCN7 MTOR ARFGAP3 FURIN CHPF2 PLD1 G6PD

1.39e-0511681511719946888
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

GALNT1 COPG1 COPG2 BTAF1 TUBGCP2 NDUFS2 SLC25A22 FOXRED2 NCAPG IGF2R PNPLA6 NUP155 MTOR ASPH CHPF2

1.63e-059421511531073040
Pubmed

Mit1/Lb9 and Copg2, new members of mouse imprinted genes closely linked to Peg1/Mest(1).

COPG1 RBL1 COPG2

1.72e-0512151310788617
Pubmed

Altered aggregation properties of mutant gamma-crystallins cause inherited cataract.

CRYGA CRYGB CRYGC

1.72e-0512151312426373
Pubmed

Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.

SEMA3F HSPG2 GALNT1 CMTR1 COPG1 ACOT9 NDUFS2 SLC25A22 MAGI2 LONP1 EEF2 IGF2R NUP155 FURIN TMEM70 ASPH DNAH6 G6PD EPB41L1

1.84e-0514511511930550785
Pubmed

Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus.

SIGLEC14 SIGLEC5

1.87e-052151224799499
Pubmed

The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression.

SIGLEC9 SIGLEC7

1.87e-052151232322597
Pubmed

Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.

SIGLEC9 SIGLEC7

1.87e-052151224569453
Pubmed

Expression of cathepsins V and S in thymic epithelial tumors.

CTSV CTSS

1.87e-052151227771373
Pubmed

Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice.

SCN1A SCN2A

1.87e-052151210827969
Pubmed

Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma.

MTOR ALK

1.87e-052151225228590
Pubmed

Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population.

SCN1A SCN2A

1.87e-052151219694741
Pubmed

Differential expression of two sodium channel subtypes in human brain.

SCN1A SCN2A

1.87e-05215121317301
Pubmed

Dasatinib enhances migration of monocyte-derived dendritic cells by reducing phosphorylation of inhibitory immune receptors Siglec-9 and Siglec-3.

SIGLEC9 CD33

1.87e-052151224882272
Pubmed

Clinical exome sequencing identifies two novel mutations of the SCN1A and SCN2A genes in Moroccan patients with epilepsy: a case series.

SCN1A SCN2A

1.87e-052151231439038
Pubmed

Co-expression of activin receptor-interacting protein 1 and 2 in mouse nerve cells.

MAGI1 MAGI2

1.87e-052151223523645
Pubmed

Differences in the constitutive and SIV infection induced expression of Siglecs by hematopoietic cells from non-human primates.

SIGLEC7 CD33

1.87e-052151218331725
Pubmed

Comparative analyses of disease risk genes belonging to the acyl-CoA synthetase medium-chain (ACSM) family in human liver and cell lines.

ACSM2A ACSM2B

1.87e-052151219634011
Pubmed

Dravet syndrome and SCN1A gene mutation related-epilepsies: cognitive impairment and its determinants.

SCN1A PCDH19

1.87e-052151221504426
Pubmed

RNA-binding proteins Rbm38 and Rbm24 regulate myogenic differentiation via p21-dependent and -independent regulatory pathways.

RBM24 RBM38

1.87e-052151219817877
Pubmed

Characterization of SMG-9, an essential component of the nonsense-mediated mRNA decay SMG1C complex.

SMG8 SMG9

1.87e-052151220817927
Pubmed

Identification of the mitochondrial glutamate transporter. Bacterial expression, reconstitution, functional characterization, and tissue distribution of two human isoforms.

SLC25A18 SLC25A22

1.87e-052151211897791
Pubmed

Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A.

SCN1A SCN2A

1.87e-052151215249644
Pubmed

Phospholipase D regulates the size of skeletal muscle cells through the activation of mTOR signaling.

MTOR PLD1

1.87e-052151223915343
Pubmed

Blockade of PLD1 potentiates the antitumor effects of bortezomib in multiple myeloma cells by inhibiting the mTOR/NF-κB signal pathway.

MTOR PLD1

1.87e-052151233191863
Pubmed

Dravet syndrome and Dravet syndrome-like phenotype: a systematic review of the SCN1A and PCDH19 variants.

SCN1A PCDH19

1.87e-052151233937968
Pubmed

Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors.

SIGLEC7 CD33

1.87e-052151211774609
Pubmed

Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14.

SIGLEC14 SIGLEC5

1.87e-052151226459514
Pubmed

Two human gamma-crystallin genes are linked and riddled with Alu-repeats.

CRYGB CRYGC

1.87e-05215124065573
Pubmed

SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.

SCN1A SCN2A

1.87e-052151230693367
Pubmed

Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma.

MTOR PLD1

1.87e-052151221228924
Pubmed

Association between SCN1A and SCN2A mutations and clinical/EEG features in Chinese patients from epilepsy or severe seizures.

SCN1A SCN2A

1.87e-052151229649454
Pubmed

The L513S polymorphism in medium-chain acyl-CoA synthetase 2 (MACS2) is associated with risk factors of the metabolic syndrome in a Caucasian study population.

ACSM2A ACSM2B

1.87e-052151216521160
Pubmed

Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells.

SIGLEC9 SIGLEC7

1.87e-052151232391973
Pubmed

PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas.

MTOR PLD1

1.87e-052151217726467
Pubmed

Fraternal twins: Swiprosin-1/EFhd2 and Swiprosin-2/EFhd1, two homologous EF-hand containing calcium binding adaptor proteins with distinct functions.

EFHD2 EFHD1

1.87e-052151221244694
Pubmed

The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.

SIGLEC9 SIGLEC7

1.87e-052151215557178
Pubmed

Dravet syndrome: a genetic epileptic disorder.

SCN1A PCDH19

1.87e-052151223093055
Pubmed

Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications.

MTOR PLD1

1.87e-052151221326806
Pubmed

Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females.

SCN1A PCDH19

1.87e-052151219214208
Pubmed

Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children.

SCN1A SCN2A

1.87e-052151233096315
Pubmed

Analysis of single nucleotide polymorphisms of CRYGA and CRYGB genes in control population of western Indian origin.

CRYGA CRYGB

1.87e-052151219384013
Pubmed

The RNA-binding protein RBM24 regulates lipid metabolism and SLC7A11 mRNA stability to modulate ferroptosis and inflammatory response.

RBM24 RBM38

1.87e-052151236478739
Pubmed

A crystallin mutant cataract with mineral deposits.

CRYGB CRYGC

1.87e-052151237331601
Pubmed

Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.

SIGLEC9 SIGLEC7

1.87e-052151215292262
Pubmed

Missense mutations in sodium channel SCN1A and SCN2A predispose children to encephalopathy with severe febrile seizures.

SCN1A SCN2A

1.87e-052151226311622
Pubmed

Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways.

MTOR CTSS

1.87e-052151224875536
Pubmed

The evolutionary fate of recently duplicated retrogenes in mice.

ACOT9 G6PD

1.87e-052151217305828
Pubmed

Analyses of the genetic diversity and protein expression variation of the acyl: CoA medium-chain ligases, ACSM2A and ACSM2B.

ACSM2A ACSM2B

1.87e-052151229948332
Pubmed

MAGI1 copy number variation in bipolar affective disorder and schizophrenia.

MAGI1 MAGI2

1.87e-052151222381734
Pubmed

Identification of SCN1A and PCDH19 mutations in Chinese children with Dravet syndrome.

SCN1A PCDH19

1.87e-052151222848613
Pubmed

Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells.

SIGLEC7 CD33

1.87e-052151210611343
Pubmed

Anaplastic lymphoma kinase and leukocyte tyrosine kinase: functions and genetic interactions in learning, memory and adult neurogenesis.

LTK ALK

1.87e-052151222079349
Pubmed

Expanding the phenotypic and allelic spectrum of SMG8: Clinical observations reveal overlap with SMG9-associated disease trait.

SMG8 SMG9

1.87e-052151234761517
Pubmed

The developmental changes of Na(v)1.1 and Na(v)1.2 expression in the human hippocampus and temporal lobe.

SCN1A SCN2A

1.87e-052151221377452
Pubmed

Fyn Activation of mTORC1 Stimulates the IRE1α-JNK Pathway, Leading to Cell Death.

ERN1 MTOR

1.87e-052151226306048
Pubmed

Nucleotide sequence of the rat gamma-crystallin gene region and comparison with an orthologous human region.

CRYGB CRYGC

1.87e-05215122777080
Pubmed

Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.

MAGI1 DDR1 GDAP1 TUBGCP2 NDUFS2 MAGI2 EEF2 TMEM160 EPB41L1 MAPK8IP2

2.00e-054301511032581705
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

SEMA3F ABCC3 HSPG2 ERCC2 SPG7 KIAA0513 BTAF1 SLC25A22 IGF2R PNPLA6 CLCN7 MTOR FURIN LTK CPVL RBM38

2.69e-0511051511635748872
Pubmed

The orchestration of mammalian tissue morphogenesis through a series of coherent feed-forward loops.

CRYGA CRYGB CRYGC

2.82e-0514151321998302
Pubmed

Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development.

CACNA1S HCN1 CLCN7 SCN1A KCNJ16 KCNN2

3.39e-05139151616985003
Pubmed

Prox1 function is crucial for mouse lens-fibre elongation.

CRYGA CRYGB CRYGC

3.51e-0515151310080188
Pubmed

A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.

COPG1 ACOT9 COPG2 TUBGCP2 NDUFS2 LONP1 NCAPG NUP155 CTR9 ASPH CPVL

3.61e-055601511135241646
InteractionEPHA1 interactions

COPG1 ACOT9 BTAF1 RBM28 SMG8 GSDMD ASPH SMG9 ZRANB1 ALK

9.04e-0623514710int:EPHA1
InteractionTULP2 interactions

WDR19 LONP1 CTR9 WDR35 MAPK8IP2

9.09e-06391475int:TULP2
Cytoband19q13.3

ERCC2 SIGLEC5 SIGLEC7 CD33 DMPK

8.01e-0682151519q13.3
Cytoband16p12.3

UMOD ACSM2A ACSM2B

1.94e-0434151316p12.3
CytobandEnsembl 112 genes in cytogenetic band chr19q13

NAPSA ERCC2 SIGLEC9 SIGLEC14 SIGLEC5 FCGBP SIGLEC7 TMEM160 CD33 SMG9 CCDC97 DMPK

6.12e-04119215112chr19q13
GeneFamilyCD molecules|C2-set domain containing|Sialic acid binding Ig like lectins

SIGLEC9 SIGLEC14 SIGLEC5 SIGLEC7 CD33

4.37e-07281015745
GeneFamilyBeta-gamma crystallins

CRYGA CRYGB CRYGC

7.33e-051510131359
GeneFamilyIntraflagellar transport proteins|Tetratricopeptide repeat domain containing

IFT172 WDR19 WDR35

3.14e-04241013615
GeneFamilyAcyl-CoA synthetase family

ACSM4 ACSM2A ACSM2B

4.01e-0426101340
GeneFamilyCalcium voltage-gated channel subunits|Membrane associated guanylate kinases

MAGI1 MAGI2 CARD14

4.01e-04261013904
GeneFamilySodium voltage-gated channel alpha subunits

SCN1A SCN2A

1.08e-03910121203
GeneFamilyReceptor Tyrosine Kinases|CD molecules

DDR1 LTK ALK

1.44e-03401013321
GeneFamilyATP binding cassette subfamily B

ABCB5 ABCB8

1.64e-03111012806
GeneFamilyKelch like|BTB domain containing

KLHL10 KLHL34 KLHL26

1.66e-03421013617
GeneFamilyAdenosine receptors|V-set domain containing

SIGLEC9 SIGLEC14 SIGLEC5 SIGLEC7 CD33

2.21e-031631015590
GeneFamilyCathepsins

CTSV CTSS

3.09e-03151012470
CoexpressionAtlaskidney_adult_RenalCortexMixed_Std_k-means-cluster#1_top-relative-expression-ranked_100

NAPSA KCNJ16 UMOD ACSM2A

3.97e-06161494gudmap_kidney_adult_RenalCortexMixed_Std_k1_100
CoexpressionAtlaskidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#4_top-relative-expression-ranked_200

NAPSA EFHD1 KCNJ16 UMOD ACSM2A

1.10e-05421495gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k4_200
CoexpressionAtlaskidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#1_top-relative-expression-ranked_100

NAPSA KCNJ16 UMOD ACSM2A

2.63e-05251494gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k1_100
CoexpressionAtlaskidney_adult_CortVasc_Tie2_k-means-cluster#1_top-relative-expression-ranked_100

NAPSA KCNJ16 UMOD ACSM2A

4.82e-05291494gudmap_kidney_adult_CortVasc_Tie2_k1_100
CoexpressionAtlaskidney_adult_CortVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_500

NAPSA SAT1 EFHD1 SLC22A2 KCNJ16 UMOD ACSM2A

7.17e-051441497gudmap_kidney_adult_CortVasc_Tie2_k4_500
CoexpressionAtlaskidney_adult_RenalCortexMixed_Std_k-means-cluster#2_top-relative-expression-ranked_200

NAPSA KCNJ16 UMOD ACSM2A

8.13e-05331494gudmap_kidney_adult_RenalCortexMixed_Std_k2_200
CoexpressionAtlaskidney_adult_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_100

NAPSA KCNJ16 UMOD ACSM2A

1.03e-04351494gudmap_kidney_adult_JuxtaGlom_Ren1_k4_100
CoexpressionAtlasdev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000

CEP85 COPG2 NCBP1 METTL4 POLR3G NCAPG MTOR PRMT9 RBM46 RBM38

1.25e-0433314910gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000
CoexpressionAtlaskidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_100

NAPSA SLC22A2 KCNJ16 UMOD ACSM2A

1.63e-04731495gudmap_kidney_adult_RenalCortexMixed_Std_100
CoexpressionAtlasDevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#5_top-relative-expression-ranked_1000

NAPSA FBLN5 INHA EFHD1 CD33 SLC22A2 UMOD ACSM2A

1.88e-042241498gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k5
CoexpressionAtlaskidney_adult_JuxtaGlom_Ren1_k-means-cluster#1_top-relative-expression-ranked_200

NAPSA EFHD1 KCNJ16 UMOD ACSM2A

1.97e-04761495gudmap_kidney_adult_JuxtaGlom_Ren1_k1_200
ToppCellCOVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type

EFHD1 SCN2A SLC22A2 KCNJ16 UMOD ACSM2A EPB41L1 ACSM2B

2.08e-0718215189d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCellFrontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

HCN1 GDAP1 GRIN1 CHGA SCN2A SYT1 MAPK8IP2 AGTPBP1

4.11e-071991518f88039d862f3bfa01dc39d2de4f3f548dc5a0e61
ToppCellKidney|World / Skin and Kidney Cells in Lupus Nephritis Patients.

IVD EFHD1 SLC22A2 KCNJ16 UMOD ACSM2A CPVL ACSM2B

4.27e-0720015181f99afa1f3c32a2a9cfb4ad33ff4d404e34fac63
ToppCellPND10-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ERCC2 MGAT4A EFHD2 POLR3G GTF3C1 RAB7B SLC45A2

1.82e-0616915173e40ae0b23a962e0f15908872dec63f51c5b8b83
ToppCellfacs-Marrow-B-cells-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1S POGK EML6 C7orf57 ALDH1A2 ARFGAP3 EDEM1

2.39e-0617615175f9ae5eb45603ed0422a3a993ecdbe2ce05d6e45
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

HSPG2 CEP85 APCDD1 DUOX1 KCNN2 SYT1 OAZ3

2.39e-0617615171df7b6ce2519ad99bacbbaf1a8d5929e11513faa
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SIGLEC9 SIGLEC14 EFHD2 SIGLEC7 CD33 CPVL CTSS

2.88e-06181151708bc6fe2a11d31a7e5e4a4552b04c0ebc2aefc59
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HCN1 GRIN1 RIT2 FGF23 SCN1A SCN2A SYT1

3.21e-0618415177d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593
ToppCell3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-cDC2|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VASH1 EFHD2 SIGLEC7 SAT1 CD33 CPVL CTSS

3.44e-06186151744785bd171f424ad61437275026439fae3cb8d8c
ToppCellCOVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type

EFHD1 SCN2A SLC22A2 KCNJ16 ACSM2A EPB41L1 ACSM2B

3.57e-061871517d23aae9419d460b78b1d4092d7acd9108a47cfbe
ToppCell3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SIGLEC14 SIGLEC7 SAT1 JMJD7 CD33 CPVL CTSS

3.69e-061881517c7c2cf1aa328e735073d6031e44b5dbd55beae6d
ToppCell10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue

ERN1 MGAT4A GTF3C1 FURIN RORC PLD1 LTK

3.83e-061891517afe3a4fe7c10eeeb7064129778d940269c9acbef
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

ERN1 MGAT4A GTF3C1 RORC LTK RBM24 RBM38

4.24e-061921517892789bdba150ef9a8a0012de52545f2ff6a31f6
ToppCellCOVID-19_Mild-Lymphoid_T/NK-MAIT|COVID-19_Mild / Disease group, lineage and cell class

ERN1 MGAT4A GTF3C1 RORC LTK RBM24 RBM38

4.24e-061921517d47bd132e57f5b4bddcf3dfa399cee149eca7e44
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ERN1 MGAT4A GTF3C1 RORC LTK RBM24 RBM38

4.24e-06192151724ea8fdcca2695aeb2e4b88161184124b7d332c1
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ERN1 MGAT4A GTF3C1 RORC LTK RBM24 RBM38

4.24e-06192151744f440ee3842fe14665c4cd4f2aa48e7a5bbd9a8
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ERN1 MGAT4A GTF3C1 RORC LTK RBM24 RBM38

4.24e-0619215178d50ad8cfe3cb9f183188b08457756af0ce56ffe
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIAA0513 HCN1 GRIN1 SCN1A SCN2A SYT1 MAPK8IP2

4.39e-0619315175fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4
ToppCellmild_COVID-19-MAIT|mild_COVID-19 / disease group, cell group and cell class (v2)

ERN1 MGAT4A GTF3C1 RORC LTK RBM24 RBM38

4.70e-061951517b99815ec94042da1a2574468331b043d29d70b38
ToppCellmild_COVID-19-MAIT|World / disease group, cell group and cell class (v2)

ERN1 MGAT4A GTF3C1 RORC LTK RBM24 RBM38

4.70e-06195151774f0f709d9b3eed5d7e02a51884f02cc281782f1
ToppCellwk_15-18-Hematologic-Myeloid-Non-cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

SIGLEC9 SIGLEC14 EFHD2 SIGLEC7 CD33 CPVL CTSS

5.02e-061971517b843e9d664f909c1c12d72b93bd2b3279ca12a59
ToppCellcellseq2-Immune-Immune_Myeloid-iMON-iMON|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SIGLEC9 SIGLEC14 EFHD2 SIGLEC7 CD33 CPVL CTSS

5.19e-061981517a6aa113f0af4d25c032f440c3134fe4d88ca5055
ToppCell5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EFHD2 SIGLEC7 SAT1 CD33 CPVL CTSS CARD14

5.19e-06198151788635244a0b306d2cc50b8412fe47bb359c9cf00
ToppCellcellseq2-Immune-Immune_Myeloid-iMON|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SIGLEC9 SIGLEC14 EFHD2 SIGLEC7 CD33 CPVL CTSS

5.19e-061981517a0ceed8689d42be6b9cde89d6c182d10b3fb14fc
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SIGLEC7 SAT1 CD33 TMEM70 PRMT9 CPVL CTSS

5.37e-061991517639539d27e8ea1cc47630a69668e6cba02f8c9ca
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SIGLEC9 SIGLEC5 EFHD2 TUBGCP2 FCGBP SIGLEC7 GSDMD

5.55e-0620015175f1de1f9305e1784c12d526f6c8bdd7d56229f9b
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KLHL10 BTAF1 C7orf57 NCAPG CPVL SEZ6

9.46e-0614315167adc34d8ad11e57950a5a258ae9bf8f52259385a
ToppCellmild_COVID-19_(asymptomatic)-MAIT|World / disease group, cell group and cell class (v2)

ERN1 MGAT4A GTF3C1 RORC LTK RBM24

1.39e-0515315162b4c69f6db17927d6506a645ac058133e60b0103
ToppCellTCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Seminoma-_NOS-5|TCGA-Testes / Sample_Type by Project: Shred V9

CMTR1 KIAA0513 IFT172 EML6 TUBGCP2 RBM24

1.99e-05163151680bc3732afd8501938753120b8403098c7c5e928
ToppCellTCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Seminoma-_NOS|TCGA-Testes / Sample_Type by Project: Shred V9

CMTR1 KIAA0513 IFT172 EML6 TUBGCP2 RBM24

1.99e-05163151667551fefe22bd5b8178fa248fed2a6c17b19fb0f
ToppCell5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VASH1 EFHD2 SAT1 CD33 CPVL CTSS

2.21e-05166151683d0c26ccee605df6b04bbca31661bf4ff4f22ba
ToppCellfacs-Kidney|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAPSA SLC22A2 KCNJ16 UMOD CTSS ACSM2B

2.36e-051681516d2f17a470e04f8f0edb111894027bcfc6ee1a12f
ToppCellCOVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type

MAGI2 ALDH1A2 SLC22A2 KCNJ16 ACSM2A EPB41L1

2.36e-051681516a086c306be430adf0632ba53e98cd8014d2de330
ToppCellfacs-Liver-Non-hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAPSA DDR1 EFHD2 SAT1 G6PD CTSS

2.44e-0516915162d3618f78484bd3508b7bdae3a0d0183cdae5057
ToppCellfacs-Liver-Non-hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAPSA DDR1 EFHD2 SAT1 G6PD CTSS

2.52e-051701516f08aa6168ff0c20b2083dbf588dd3294e3d9580e
ToppCellTCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8|TCGA-Liver / Sample_Type by Project: Shred V9

FBLN5 SLC25A18 FURIN EDEM1 ACSM2A ACSM2B

2.61e-051711516c4a919fe3d56ae6df2fcab6686abacc10befc053
ToppCellfacs-Liver-Non-hepatocytes-24m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAPSA DDR1 EFHD2 CRLF2 G6PD CTSS

2.69e-05172151666823536288c7009ce01b5177794a3e874e94570
ToppCellControl-MAIT|Control / Disease group and Cell class

ABCC3 DDR1 ERN1 PEX12 RORC GCC1

2.69e-051721516552bc62e8e8bb0ac1cd0452f4410a3af087787eb
ToppCellfacs-Trachea-18m-Hematologic-myeloid|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NAPSA EFHD2 CRLF2 CD33 RAB7B CTSS

2.69e-051721516c260680f5455fce133b7b4158b4197fc76115779
ToppCellPND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RBL1 EML6 POLR3G FOXRED2 P2RX5 EPB41L1

2.69e-051721516eba1568d4307e91c94fc616549057cbed8df5840
ToppCell368C-Myeloid-Macrophage-SPP1+_Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells)

ABCC3 SIGLEC9 EFHD2 LIMK1 PNPLA6 CTSS

2.78e-051731516bba8265a58f8f5659dc7b9da2fe27b15033fce34
ToppCelltumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

SIGLEC9 CLCN7 CD33 SLC45A2 CPVL CTSS

2.78e-0517315168384d533a1071fc65a06e6d9f5f17d8ab00c3966
ToppCell5'-Adult-LymphNode-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NAPSA SIGLEC5 PLEKHG4B EEF2 CD33 CPVL

3.16e-05177151623c1bce4ae3b94f56263f5a9f6bbd1805c097a12
ToppCellwk_20-22-Hematologic-Myeloid-pre-pDC/DC5|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

NAPSA SIGLEC14 SIGLEC5 CD33 RAB7B LTK

3.16e-0517715166de3c623f8595d7e3827df99b806bc9f1f15b3b7
ToppCellE16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LYZL4 GDAP1 CHGA SYT1 DMPK MAPK8IP2

3.26e-051781516d3a75a8082e70543b84c35d53fe77625300d19fa
ToppCellE16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LYZL4 GDAP1 CHGA SYT1 DMPK MAPK8IP2

3.26e-051781516b2cda1df801b1a1a41e3dd2808baef37765cd804
ToppCell3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYO1H GRIN1 CRYGC SCN2A SYT1 LTK

3.37e-051791516228d12ed1c8dc92aefbcea4aaf7d108783c22be0
ToppCellfacs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NAPSA CACNA1S EFHD2 RAB7B SLC45A2 CTSS

3.37e-051791516b7a2429d07d7146b32b3552a5f2a2542105a71e0
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SIGLEC9 SIGLEC7 SAT1 CD33 CPVL CTSS

3.48e-0518015167af90f0e7ca001bf1fe5c860ee54c4cc8eb483bf
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ERN1 MGAT4A GTF3C1 RORC LTK RBM24

3.70e-051821516f30e5a21b49f30b82e2b6f1fd2daefd805a40083
ToppCellCOVID-19_Severe-Lymphoid_T/NK-MAIT|COVID-19_Severe / Disease group, lineage and cell class

ERN1 MGAT4A GTF3C1 RORC LTK RBM24

3.70e-05182151619045db5c726c06ec6e4feb4311633c8164ddb3c
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ERN1 MGAT4A GTF3C1 RORC LTK RBM24

3.70e-051821516cccac9f85825f4e310b86e37ee6320769a670501
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ERN1 MGAT4A GTF3C1 RORC LTK RBM24

3.70e-0518215161444cdc4522a70a40d697ccadf54cf26d327ade0
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

ERN1 MGAT4A GTF3C1 RORC LTK RBM24

3.70e-05182151649eced222e8f90c2b59bcc7d56b62c3e703fcce5
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBLN5 SLC25A18 IGDCC4 KCNN2 RBM46 RBM24

3.81e-05183151699bb4ceb92f6467f2359a42ab2cff6df18825a30
ToppCelldroplet-Kidney-nan-24m-Lymphocytic-plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1S ERN1 CRLF2 EDEM1 CTSS SP140

3.93e-05184151682d2daa39e3c31a74c08a5d77366740b87beb2fb
ToppCellwk_08-11-Hematologic-Myeloid-DC3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

SIGLEC9 SIGLEC14 SIGLEC7 CD33 CPVL CTSS

3.93e-0518415167d9294e5a55964903feda135e5bea0338824ed83
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SIGLEC9 SIGLEC7 SAT1 CD33 CPVL CTSS

4.05e-05185151600a991e63e9ac6de3f48a96e3be6073f90cbb442
ToppCell5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RIT2 CRYGC SCN2A SYT1 LTK SEZ6

4.17e-05186151618fd311252299d6d30ddb32002ed069056108206
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SIGLEC5 ALDH1A2 PNPLA6 CD33 CPVL CTSS

4.17e-051861516cb7df8da6478b96955f3ef1394a0655ec8061bba
ToppCellFetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

HCN1 EML6 CHGA SCN2A SYT1 MAPK8IP2

4.17e-051861516b45cce768e4bf91da194fd9660cab7520dfb15ac
ToppCellfacs-Bladder|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCC3 FBLN5 MGAT4A ALDH1A2 ARFGAP3 GSDMD

4.30e-051871516dd5ca59417fd1b388fd975f0f3e1f3245d66ebc5
ToppCellwk_08-11-Epithelial-PNS-MFNG+_DBH+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

CHGA SYT1 RBM24 ALK MAPK8IP2 SEZ6

4.43e-051881516d3d7d21d4fa39ac4106a164652673de1bef8662d
ToppCellcontrol-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

KIAA0513 CD33 RORC GCC1 RBM24 CPVL

4.56e-051891516bdfd120900ba58d5e54765f7b576e1f8cc2401bf
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HCN1 GRIN1 SCN1A SCN2A SYT1 MAPK8IP2

4.56e-051891516f57200c93d39c9bce1adba0a6a1c178c028dd86b
ToppCellGlobus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

INHA GRIN1 CHGA SCN2A SYT1 MAPK8IP2

4.70e-051901516416de85d8841dac883faa6f5339b2fb461a09e82
ToppCell3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VASH1 SIGLEC7 SAT1 CD33 CPVL CTSS

4.84e-05191151694c7da03e5264f4d73bb507ce339a935d90279a0
ToppCellCOVID-19_Mild-MAIT|COVID-19_Mild / Disease condition and Cell class

ERN1 GTF3C1 FURIN RORC LTK RBM24

4.84e-051911516e834d7a6aa7bb4f194b203d351e53bf5d95175d6
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32

CMTR1 CHGA RIT2 LIMK1 SCN2A SYT1

4.84e-0519115165d24022cec293bc8d9e978ae99a109e660bb8f83
ToppCellEntopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32

CMTR1 CHGA RIT2 LIMK1 SCN2A SYT1

4.84e-05191151673dae4cdea86aec62393ad7303dc7375a6b3fc86
ToppCellEntopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32

CMTR1 KIAA0513 CHGA RIT2 SCN2A SYT1

4.98e-0519215164c35e5c28a40b439044797ba1f06cb7c36b2a8de
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SIGLEC9 SIGLEC14 SIGLEC7 SAT1 CPVL CTSS

4.98e-05192151662eac1b8aed4fb924946b58c0237313f697a0136
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRIN1 SCN1A SCN2A SYT1 LTK SEZ6

5.12e-051931516be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MAGI1 EFHD1 KCNJ16 ACSM2A EPB41L1 ACSM2B

5.12e-05193151682e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCellPosterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

GDAP1 GRIN1 CHGA SCN2A SYT1 MAPK8IP2

5.12e-051931516b4989e3436e84dbec3789b46057e0f7a0ebf09d4
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRIN1 SCN1A SCN2A SYT1 LTK SEZ6

5.12e-0519315160c652ebe22ce5d2927599dd97ef1920547858395
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRIN1 SCN1A SCN2A SYT1 LTK SEZ6

5.12e-0519315168689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SIGLEC9 VASH1 SIGLEC7 CD33 CPVL CTSS

5.27e-0519415167c7091de47359760003e910cfbe63db5c99410d6
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MAGI1 ABCC3 KCNJ16 ACSM2A EPB41L1 ACSM2B

5.27e-0519415167002937e8903e037332a215d00fbc7c7843b33f2
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-cDC2|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VASH1 SIGLEC7 SAT1 CD33 CPVL CTSS

5.43e-051951516d9bdb37bc562c42fb73fdc3f4150335511b3ef9b
ToppCell15-Airway-Immune-Hematopoietic,_Macrophage|Airway / Age, Tissue, Lineage and Cell class

SIGLEC9 SIGLEC5 EFHD2 CD33 CPVL CTSS

5.43e-051951516705aa5442c61d5fdc0aafb2ad40b8c9d2dc566c6
ToppCell5'-Adult-SmallIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SIGLEC9 SIGLEC7 SAT1 CD33 CPVL CTSS

5.43e-051951516f289a44010788853d7726d4b5aa75f3c62186c08
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SIGLEC9 FCGBP SAT1 TMEM70 CPVL CTSS

5.43e-051951516d07a8cfecf7a54cf6274565b1649e735abb79c87
ToppCell3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GRIN1 RIT2 PCDH19 SYT1 LTK MAPK8IP2

5.43e-0519515165a6a5048af638872700b76b7c71a8fa3fb8d3772
ToppCellFrontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Crh_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

ABCB5 FAM170B FGF23 ACSM4

5.48e-05611514351078cb41e285af7e117820ee607d4c24332a9d
ToppCellFrontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Crh_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

ABCB5 FAM170B FGF23 ACSM4

5.48e-05611514aae9ba2240812258d1c9e0e443d4f817b4796131
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

VASH1 SIGLEC5 ALDH1A2 SAT1 RAB7B

5.57e-05120151516c3bd15e3936b68c433c4dd15d655aae64dc960
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SIGLEC5 PNPLA6 SIGLEC7 CD33 CPVL CTSS

5.58e-051961516eb7d6bbfb766cdeaf5fe0f0bb66a5f491fd5ef26
ToppCell11.5-Airway-Immune-Hematopoietic,_Macrophage|Airway / Age, Tissue, Lineage and Cell class

SIGLEC14 SIGLEC5 SIGLEC7 CD33 CPVL CTSS

5.58e-051961516f73573b5d9c735f2a2c718472b7d12b10f2a3718
ToppCellcontrol-immature_Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

KIAA0513 RORC GCC1 RBM24 ZRANB1 AGTPBP1

5.58e-051961516e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4
ToppCellfrontal_cortex-Neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

GDAP1 GRIN1 CHGA RIT2 SCN2A SYT1

5.58e-051961516de7d10da862f98894ce47244fbc992f4a12d63bb
ToppCell3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SIGLEC14 EFHD2 SAT1 CD33 CPVL CTSS

5.58e-051961516a692cee9254f3771a076b290688a4d0120c02c3b
ToppCell3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SIGLEC14 SIGLEC7 SAT1 CD33 CPVL CTSS

5.58e-051961516fa24d7c4b7c65e98b209db302a16c58ceac1a105
ToppCell(2)_NK/T-(220)_CD8+_Cytotoxic_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)

ERN1 EFHD2 GTF3C1 RORC LTK RBM24

5.58e-051961516d123361c32bcd2329200f0316bc5b54bb494e92d
ToppCellCOVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type

SIGLEC9 ALDH1A2 SAT1 CD33 CPVL CTSS

5.74e-051971516a0f8a992282a6d64890f5574c7c9741fcb38dadd
ToppCellwk_08-11-Hematologic-Myeloid-APOE+_Mac1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

SIGLEC9 SAT1 CD33 CPVL CTSS OPLAH

5.74e-051971516121ec3f6d978de2f6c2cc397f7327d2e5587ab8b
ToppCell5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CHGA SCN2A SYT1 ALK MAPK8IP2 SEZ6

5.74e-051971516a1ae1aa797762a3768e14434c7e5cd19c595ecb3
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

ERN1 MGAT4A GTF3C1 RORC LTK RBM24

5.74e-051971516a4ecac6ee8a0d4d85319104c179ec7711a3efb51
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SIGLEC9 SIGLEC7 SAT1 CD33 CPVL CTSS

5.74e-051971516e698a0bbb20bd4868ff4348f2ac9f609942b55fa
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MGAT4A FCGBP SAT1 CD33 CPVL CTSS

5.74e-051971516769a4203c014b34d16d4d76d3caf07ddb2c41abc
Drugpolysialoganglioside

SIGLEC9 SIGLEC5 SIGLEC7 CD33 SYT1 CPVL

9.25e-07501506CID006450319
DrugNSC 284682

ABCB5 LONP1 MTOR ALK

3.10e-06161504CID000072518
DiseaseGeneralized Epilepsy with Febrile Seizures Plus

HCN1 SCN1A SCN2A

1.02e-0591483C3502809
DiseaseX-21319 measurement

ACSM2A ACSM2B

2.50e-0521482EFO_0800807
DiseaseInfantile Severe Myoclonic Epilepsy

SCN1A PCDH19 SCN2A

3.41e-05131483C0751122
Diseasecataract (implicated_via_orthology)

CRYGA SLC45A2 RBM24 G6PD

3.93e-05381484DOID:83 (implicated_via_orthology)
DiseaseEpilepsy, Cryptogenic

ERN1 HCN1 SCN1A PCDH19 SCN2A

5.93e-05821485C0086237
DiseaseAwakening Epilepsy

ERN1 HCN1 SCN1A PCDH19 SCN2A

5.93e-05821485C0751111
DiseaseAura

ERN1 HCN1 SCN1A PCDH19 SCN2A

5.93e-05821485C0236018
DiseaseEarly infantile epileptic encephalopathy with suppression bursts

SLC25A22 SCN1A SCN2A

6.60e-05161483C0393706
DiseaseX-11478 measurement

ACSM2A ACSM2B

7.47e-0531482EFO_0021242
Diseasemetabolite measurement

ABCC3 NCBP1 IVD MAGI2 ALDH1A2 IGF2R SLC22A2 ABCB8 SYT1 ACSM2A G6PD

1.28e-0456014811EFO_0004725
DiseaseCranioectodermal dysplasia

WDR19 WDR35

1.49e-0441482cv:C4551571
Diseaseanxiety disorder (implicated_via_orthology)

HCN1 SCN1A SCN2A

1.78e-04221483DOID:2030 (implicated_via_orthology)
DiseaseEpilepsy

ERN1 HCN1 SCN1A PCDH19 SCN2A

2.28e-041091485C0014544
DiseaseLateral Sclerosis

SPG7 PNPLA6

2.47e-0451482C0154682
DiseaseCRANIOECTODERMAL DYSPLASIA 1

WDR19 WDR35

2.47e-0451482C0432235
Diseaseneuroblastoma (implicated_via_orthology)

LTK ALK

2.47e-0451482DOID:769 (implicated_via_orthology)
Disease3-hydroxyhexanoate measurement

ACSM2A ACSM2B

2.47e-0451482EFO_0800378
Diseaseacute lymphoblastic leukemia

METTL4 RIT2 WDR19 MAGI2

3.44e-04661484EFO_0000220
DiseaseEPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1

HCN1 SCN1A

3.70e-0461482C3463992
Diseaseindoleacetoylcarnitine measurement

ACSM2A ACSM2B

3.70e-0461482EFO_0800106
DiseaseEpileptic encephalopathy

GRIN1 MAGI2 MTOR

4.55e-04301483C0543888
DiseaseSeizure, Febrile, Simple

SCN1A SCN2A

5.16e-0471482C0149886
DiseaseSeizure, Febrile, Complex

SCN1A SCN2A

5.16e-0471482C0751057
Diseaseretinal degeneration (implicated_via_orthology)

NMNAT1 IFT172 CRYGC

6.04e-04331483DOID:8466 (implicated_via_orthology)
DiseaseX-linked infantile spasms

HCN1 SCN1A

6.86e-0481482C4552072
DiseaseMitochondrial Encephalomyopathies

NDUFS2 TMEM70

6.86e-0481482C0162666
Diseasesialic acid-binding Ig-like lectin 9 measurement

SIGLEC9 SIGLEC7

8.79e-0491482EFO_0008286
Diseasesialic acid-binding ig-like lectin 7 measurement

SIGLEC9 SIGLEC7

8.79e-0491482EFO_0020739
DiseaseFebrile Convulsions

SCN1A SCN2A

8.79e-0491482C0009952
Diseasecystic fibrosis (implicated_via_orthology)

ABCB5 EDEM1

8.79e-0491482DOID:1485 (implicated_via_orthology)
DiseaseX-18921 measurement

RORC ACSM2A

8.79e-0491482EFO_0800796
DiseaseConventional (Clear Cell) Renal Cell Carcinoma

DNHD1 ERN1 EEF2 MTOR ALK

9.22e-041481485C0279702
Diseasedolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement

SIGLEC14 SIGLEC5

1.10e-03101482EFO_0801544
Diseasegeneralized epilepsy with febrile seizures plus 2 (implicated_via_orthology)

SCN1A SCN2A

1.10e-03101482DOID:0111294 (implicated_via_orthology)
DiseaseDravet syndrome (implicated_via_orthology)

SCN1A SCN2A

1.10e-03101482DOID:0080422 (implicated_via_orthology)
Diseasetriglycerides in large LDL measurement

ALDH1A2 IGF2R SLC22A2

1.32e-03431483EFO_0022319
DiseaseJeune thoracic dystrophy

IFT172 WDR19

1.33e-03111482C0265275
DiseasePancreatic Ductal Adenocarcinoma

ACOT9 ABCB5

1.33e-03111482C1335302
Diseasecerebrospinal fluid biomarker measurement

SIGLEC9 SIGLEC5 SIGLEC7 CD33

1.41e-03961484EFO_0006794
Diseasesialic acid-binding Ig-like lectin 14 measurement

SIGLEC14 SIGLEC5

1.60e-03121482EFO_0008284
DiseaseCharcot-Marie-Tooth disease (is_implicated_in)

FBLN5 GDAP1

1.60e-03121482DOID:10595 (is_implicated_in)
Diseasegeneralized epilepsy with febrile seizures plus (implicated_via_orthology)

SCN1A SCN2A

1.60e-03121482DOID:0060170 (implicated_via_orthology)
Diseasehair colour measurement, hair morphology measurement

SPG7 SLC45A2

1.60e-03121482EFO_0007821, EFO_0007822
DiseaseNeurobehavioral Manifestations

NMNAT1 MAGI2

1.60e-03121482C0525041
DiseaseRespiratory Depression

CACNA1S FBLN5

1.88e-03131482C0235063
DiseaseRespiratory Insufficiency

CACNA1S FBLN5

1.88e-03131482C0035229
DiseaseShort Rib-Polydactyly Syndrome

IFT172 WDR35

1.88e-03131482C0036996
DiseaseRespiratory Failure

CACNA1S FBLN5

1.88e-03131482C1145670
DiseaseSaldino-Noonan Syndrome

IFT172 WDR35

2.19e-03141482C0036069
DiseaseMajewski Syndrome

IFT172 WDR35

2.19e-03141482C0024507
Diseasephospholipids in medium VLDL measurement

ALDH1A2 IGF2R SLC22A2

2.28e-03521483EFO_0022154
Diseasecholesterol in small VLDL measurement

ALDH1A2 IGF2R SLC22A2

2.41e-03531483EFO_0022228
DiseaseMMR-related febrile seizures

SCN1A SCN2A

2.51e-03151482EFO_0006519
DiseaseNeoplasm of uncertain or unknown behavior of bladder

ERCC2 MTOR

2.51e-03151482C0496930
Diseasemyeloid cell surface antigen CD33 measurement

SIGLEC7 CD33

2.51e-03151482EFO_0008238
DiseaseBenign neoplasm of bladder

ERCC2 MTOR

2.51e-03151482C0154017
DiseaseCarcinoma in situ of bladder

ERCC2 MTOR

2.51e-03151482C0154091
Diseasetriglycerides in IDL measurement

ALDH1A2 IGF2R SLC22A2

3.12e-03581483EFO_0022149
DiseaseMAJOR AFFECTIVE DISORDER 2

MAGI1 MAGI2

3.23e-03171482C1839839
Diseasephospholipids in VLDL measurement

ALDH1A2 IGF2R SLC22A2

3.27e-03591483EFO_0022301
Diseasefree cholesterol in VLDL measurement

ALDH1A2 IGF2R SLC22A2

3.60e-03611483EFO_0022276
Diseasebrain infarction

APCDD1 ALK

3.63e-03181482EFO_0004277
DiseaseFebrile seizure (within the age range of 3 months to 6 years)

SCN1A SCN2A

3.63e-03181482HP_0002373
DiseaseCarcinoma of bladder

ERCC2 MTOR

3.63e-03181482C0699885
DiseaseSarcomatoid Renal Cell Carcinoma

DNHD1 EEF2 MTOR ALK

4.01e-031281484C1266043
DiseaseChromophobe Renal Cell Carcinoma

DNHD1 EEF2 MTOR ALK

4.01e-031281484C1266042
DiseaseCollecting Duct Carcinoma of the Kidney

DNHD1 EEF2 MTOR ALK

4.01e-031281484C1266044
DiseasePapillary Renal Cell Carcinoma

DNHD1 EEF2 MTOR ALK

4.01e-031281484C1306837
DiseaseRenal Cell Carcinoma

DNHD1 EEF2 MTOR ALK

4.01e-031281484C0007134
Diseasecarotid artery disease (is_marker_for)

HSPG2 CTSS

4.04e-03191482DOID:3407 (is_marker_for)
Diseaseinferior parietal cortex volume measurement

CRYGB CRYGC

4.04e-03191482EFO_0010307
Diseasetotal lipids in small VLDL

ALDH1A2 IGF2R SLC22A2

4.68e-03671483EFO_0022148
Diseasesquamous cell carcinoma

SLC45A2 CTSS EPB41L1

4.68e-03671483EFO_0000707
Diseasetriglycerides in very small VLDL measurement

ALDH1A2 IGF2R SLC22A2

4.88e-03681483EFO_0022144
Diseasekidney disease (biomarker_via_orthology)

ABCC3 G6PD

4.93e-03211482DOID:557 (biomarker_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
FGNVKAISSDMYFGR

ARFGAP3

421

Q9NP61
LFRMGFRDEAAGYFH

PRMT9

111

Q6P2P2
GFMARAFQYVKENGG

CTSV

181

O60911
NGREMGEFGLREYSE

ALDH1A2

491

O94788
FMQGLFYGRAGEILT

ABCB5

751

Q2M3G0
GFRFGAYLIQAGRMT

ABCB5

936

Q2M3G0
DRGIKDEDGYFQFMG

ACSM2A

446

Q08AH3
KIADFGMSRNLYAGD

DDR1

781

Q08345
RGRSFHFYDAMDGQI

GSDMD

76

P57764
SEVGNDRKMFLFGTY

ARL9

146

Q6T311
IFNRIFGGFLMRKAY

ACOT9

306

Q9Y305
MGKITFYEDRDFQGR

CRYGA

1

P11844
IRGDFYVTGDRGVMD

ACSM4

446

P0C7M7
RFYFHLGDAMQRVGN

ASPH

526

Q12797
RAAMQELAASVFYGG

DNHD1

4311

Q96M86
FEVSGMRPGVAYRFN

AGTPBP1

751

Q9UPW5
YRAMFALRNAGGEEA

DOHH

176

Q9BU89
DTRYFFKMGARTEVG

IGDCC4

916

Q8TDY8
SRGYGFVTMADRAAA

RBM24

51

Q9BX46
GFGYVTFSMLEDVQR

RBM28

46

Q9NW13
GYGFVTMADRAAAER

RBM38

76

Q9H0Z9
RLMMEFSGENRGYAF

RBM46

91

Q8TBY0
SGDLGSGDFQMVYFR

HSPG2

71

P98160
GQERFRSMVSTFYKG

RAB7B

66

Q96AH8
RGGYFDEFGIIRDVM

G6PD

246

P11413
FNSYGARRGNDAVMT

IREB2

781

P48200
IAARGIFYGMARDAG

ABCC3

1511

O15438
RDFMRGYVEKIFSGG

KIAA0513

96

O60268
SRLMFRMYDFDGNGL

DUOX1

856

Q9NRD9
GRVTYDMTEGDRGFF

PCDH19

601

Q8TAB3
YFRIGKFENGVAEGM

MGAT4A

486

Q9UM21
GPRSDFDMAYERGRI

PNPLA6

431

Q8IY17
FLVMGSKFRYSGRTQ

EPB41L1

386

Q9H4G0
MAVLRGAVFAFLGRY

KLHL34

521

Q8N239
NDRGALLRAFSYMGF

OAZ3

186

Q9UMX2
TREGYTGFGLFQMRG

LYZL4

66

Q96KX0
GFGFSLRGGREYNMD

MAGI1

1161

Q96QZ7
GFGFSIRGGREYKMD

MAGI2

1156

Q86UL8
RNYNFGGEFVEAMIR

NCBP1

96

Q09161
RKRLSDYALIFGMFG

KCNN2

131

Q9H2S1
TPDGYADAVRGDRFM

JMJD7

86

P0C870
RDNGSYFFRMERGST

CD33

111

P20138
NMRTGERGVFPAFYA

MAPK8IP2

646

Q13387
AGRRGQDLMGDVYFF

DDX60

1326

Q8IY21
IQGGEYFSDEQMRFR

CCDC97

166

Q96F63
GLINFGRFDSEKMAY

CLCN7

356

P51798
LRAFDMINRFIYGKG

CPVL

456

Q9H3G5
KIGDFGMARDIYRAS

LTK

661

P29376
FGRGIFNYMRLGSEE

OR3A2

261

P47893
GVGYFAFMLFRKRLG

GDAP1

331

Q8TB36
TVRSEGYFGMYRGAA

SLC25A22

56

Q9H936
RAIRGKTDYGLMVFA

ERCC2

666

P18074
NREYFRFSVGGMTDV

LONP1

541

P36776
GMASVISRLDFNGFY

TUBGCP2

851

Q9BSJ2
IAGKFQFSRGMRRSY

POGK

186

Q9P215
QFSRGMRRSYDAGFK

POGK

191

Q9P215
YEFDVRARDGGSPAM

PCDHGC4

316

Q9Y5F7
IGGFTFVMNDRSYVA

CRLF2

356

Q9HC73
AGLQMAYFLQRAGRD

FOXRED2

41

Q8IWF2
GYINDFPMGRFLRDA

IVD

386

P26440
SKFGERIPAEMARFY

DMPK

161

Q09013
EEGLYFAARDRGMRD

FAM170B

56

A6NMN3
EEALNYGFSGVMLRG

NDUFS2

281

O75306
RAFFRYGGEAQMRFP

NUP155

571

O75694
GEGTDFYQVRARLAM

IFT172

676

Q9UG01
MAGGLFSIDRDYFQE

GALNT1

291

Q10472
DPMGAFQRFARESGY

DNAH6

3551

Q9C0G6
FEDAEGPRRQYGFMQ

HCN1

81

O60741
AGRAYAAEQMEGFEL

GCC1

276

Q96CN9
MGGFDGYVRLNTAER

KLHL10

391

Q6JEL2
DYFRAMFTGGMREAS

KLHL26

86

Q53HC5
GDSFYIRVNLAMEGR

CARD14

676

Q9BXL6
MPGFLGTERQFAARY

BTAF1

1451

O14981
AEGTIVYRGMFDNRD

ERN1

581

O75460
LGMQLFGGRYDFEDT

CACNA1S

576

Q13698
GRRFDFMGTCVYVLA

FCGBP

2466

Q9Y6R7
ARAEGFFGMYRGAAV

SLC25A18

56

Q9H1K4
YASRRGPFDFDMKTV

C7orf57

141

Q8NEG2
GFSFRGVKVYTMDRG

FURIN

741

P09958
RRYLCMDFRGNIFGS

FGF23

91

Q9GZV9
RDLMYFSGATGENGI

CEP85

146

Q6P2H3
RLGAMARDKGNFYEA

CTR9

536

Q6PD62
MGYSVEKYRRRGNGT

GLYATL1B

231

A0A0U1RQE8
KMEQDARGRYLLFNG

APCDD1

426

Q8J025
LSNMLRDDGGFEYKR

COPG2

401

Q9UBF2
MGKITFYEDRAFQGR

CRYGB

1

P07316
RDLARGMFVFGYDNY

EDEM1

131

Q92611
ESMFKLYDAGRDGFI

EFHD1

96

Q9BUP0
GLAQEAEEGLFRYMF

INHA

101

P05111
FVFGGRYRDARMNDL

KLHDC2

231

Q9Y2U9
GHNFGEEGYIRMARN

CTSS

301

P25774
MGKITFYEDRAFQGR

CRYGC

1

P07315
LFTMLREEGGFEYKR

COPG1

401

Q9Y678
MVPTSDKGRFYAFGR

EEF2

401

P13639
LQTNDGAGERLFYRM

EML6

466

Q6ZMW3
FKQYDAGRDGFIDLM

EFHD2

101

Q96C19
FQIKSGNEGREFYMR

FBLN5

381

Q9UBX5
GGRGNKFAQMRYSLR

CFAP69

471

A5D8W1
FIGSMSIGYIADRFG

SLC22A2

161

O15244
LFFTDFMGQIVYRGD

SLC45A2

336

Q9UMX9
GGNYEMFTRKFVFRP

METTL4

76

Q8N3J2
VFDRMFTNPRDSYGK

CMTR1

246

Q8N1G2
RKQYGGDFLRARMSS

NXPE1

131

Q8N323
YGIRFDVMVNGKGAF

P2RX5

316

Q93086
VRGLSAGARVFEYMA

ABCB8

436

Q9NUT2
RLYFGERNVKGMFEV

MTOR

2036

P42345
FVGFEYEDSRGRRFM

SMG8

846

Q8ND04
GDIYFKLFRASGDMR

IGF2R

2151

P11717
GGKTLVMAVYDFDRF

SYT1

221

P21579
SRRMQNFAFSGGLYG

PPP1R8

251

Q12972
GVYIDFMGTDAAIFR

SEMA3F

221

Q13275
LYGRMSFRGFNPEVE

MPHOSPH6

71

Q99547
MDGKEYQAGRFARGL

PLD1

941

Q13393
FVYTKGNFRMIGDDL

RBL1

181

P28749
FTAMREQYMRGGEGF

RIT2

81

Q99578
GDFGAAFVERYMREF

OPLAH

606

O14841
YVFRAQSAEMKERGG

SMG9

236

Q9H0W8
GDARMEDTGSYFFRV

SIGLEC5

106

O15389
SDAGRYFFRMEKGNI

SIGLEC7

116

Q9Y286
RSDAGRYFFRMEKGS

SIGLEC9

111

Q9Y336
LEDFFVMSDYRGFGI

SAT1

91

P21673
MVARFFLQLGDYGSA

WDR19

956

Q8NEZ3
KRTGFFGNALYSVGM

SPG7

246

Q9UQ90
SFSENFYGLKRIVMG

PEX12

81

O00623
SRDQLGRQTDFGMYD

PI4KAP2

391

A4QPH2
IFGMSNFAYVKREVG

SCN1A

1686

P35498
AKIGDFGMARDIYRA

ALK

1266

Q9UM73
DRGIKDEDGYFQFMG

ACSM2B

446

Q68CK6
SMKLSFRARAYGFRG

CHGA

371

P10645
RGDFSYIGNLMTKEF

NCAPG

386

Q9BPX3
NGYRRFDPARGMEYT

CHPF2

431

Q9P2E5
GMFYAVRRGRKTGVF

RNASEH1

26

O60930
NIGYLRFDMFGDGEL

RBP3

1041

P10745
ADNRTVFFEGKYGGM

RORC

371

P51449
VFFEGKYGGMELFRA

RORC

376

P51449
GRFSVQMFRFAGNYD

UMOD

546

P07911
GRSFLRHEEQFGMYV

PLEKHG4B

881

Q96PX9
TIRFSYFALIGMRDG

KCNJ16

181

Q9NPI9
IFGMSNFAYVKREVG

SCN2A

1676

Q99250
AAAGMALRYEAFQQG

SEZ6

516

Q53EL9
MAGNKGRGRAAYTFN

POLR3G

1

O15318
YKDFGQMGFRLEAEF

SP140

836

Q13342
LGYNMRSNLFRGAAE

TEX33

201

O43247
QSDMGREAAYGFFLL

TMEM160

91

Q9NX00
DGRLIYTGNMARAVF

TMEM70

91

Q9BUB7
YQDKALVGDFMNRRG

GTF3C1

1341

Q12789
SMKQAEVVGYFGRFE

WDR35

741

Q9P2L0
FAGRYGALGMSRRED

VASH1

211

Q7L8A9
GDARMEDTGSYFFRV

SIGLEC14

106

Q08ET2
FSALVAMENDGYGNR

ZRANB1

586

Q9UGI0
TMDFGLNVRGFLDRY

LIMK1

556

P53667
SRFGKYMDIQFDFQG

MYO1H

161

Q8N1T3
VFLGTYVAVFDRGDM

NAPSA

376

O96009
ELFFRSGFGIGMRKD

GRIN1

751

Q05586
RLFELAKDYMNGTGR

NMNAT1

26

Q9HAN9